182
Views
0
CrossRef citations to date
0
Altmetric
RAPID COMMUNICATION

Platelet/Lymphocyte Ratio Predicted Long-Term Prognosis for Acute Upper Extremity Deep Vein Thrombosis from a Retrospective Study

ORCID Icon, & ORCID Icon
Pages 225-234 | Received 24 Nov 2022, Accepted 10 Jan 2023, Published online: 14 Jan 2023

References

  • Mai C, Hunt D. Upper-extremity deep venous thrombosis: a review. Am J Med. 2011;124(5):402–407. doi:10.1016/j.amjmed.2010.11.022
  • Klitfod L, Broholm R, Baekgaard N. Deep venous thrombosis of the upper extremity. A Review Int Angiol. 2013;32(5):447–452.
  • Kearon C. Natural history of venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I22–30. doi:10.1161/01.CIR.0000078464.82671.78
  • Wendelboe AM, Raskob GE. Global Burden of Thrombosis: epidemiologic Aspects. Circ Res. 2016;118(9):1340–1347. doi:10.1161/CIRCRESAHA.115.306841
  • McLendon K, Goyal A, Bansal P, et al. Deep Venous Thrombosis Risk Factors. Treasure Island (FL): StatPearls Publishing; 2021:29262230.
  • Bartlett MA, Mauck KF, Stephenson CR, et al. Perioperative Venous Thromboembolism Prophylaxis. Mayo Clin Proc. 2020;95(12):2775–2798. doi:10.1016/j.mayocp.2020.06.015
  • Mozos I, Malainer C, Horbańczuk J, et al. Inflammatory Markers for Arterial Stiffness in Cardiovascular Diseases. Front Immunol. 2017;8:1058. doi:10.3389/fimmu.2017.01058
  • Neupane R, Jin X, Sasaki T, et al. Immune Disorder in Atherosclerotic Cardiovascular Disease― Clinical Implications of Using Circulating T-Cell Subsets as Biomarkers ―. Circ J. 2019;83(7):1431–1438. doi:10.1253/circj.CJ-19-0114
  • Kremers B, Wübbeke L, Mees B, et al. Plasma Biomarkers to Predict Cardiovascular Outcome in Patients With Peripheral Artery Disease: a Systematic Review and Meta-Analysis. Arterioscler Thromb Vasc Biol. 2020;40(9):2018–2032. doi:10.1161/ATVBAHA.120.314774
  • Ates H, Ates I, Kundi H, et al. Diagnostic validity of hematologic parameters in evaluation of massive pulmonary embolism. J Clin Lab Anal. 2017;31(5):e22072. doi:10.1002/jcla.22072
  • Bi W, Liang S, He Z, et al. The Prognostic Value of the Serum Levels of Brain Natriuretic Peptide, Troponin I, and D-Dimer, in Addition to the Neutrophil-to-Lymphocyte Ratio, for the Disease Evaluation of Patients with Acute Pulmonary Embolism. Int J Gen Med. 2021;14:303–308. doi:10.2147/IJGM.S288975
  • Liu C, Zhan HL, Huang ZH, et al. Prognostic role of the preoperative neutrophil-to-lymphocyte ratio and albumin for 30-day mortality in patients with postoperative acute pulmonary embolism. BMC Pulm Med. 2020;20(1):180. doi:10.1186/s12890-020-01216-5
  • Karataş MB, Ipek G, Onuk T, et al. Assessment of Prognostic Value of Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Patients with Pulmonary Embolism. Acta Cardiol Sin. 2016;32(3):313–320. doi:10.6515/acs20151013a
  • Gok M, Kurtul A. A novel marker for predicting severity of acute pulmonary embolism: systemic immune-inflammation index. Scand Cardiovasc J. 2021;55(2):91–96. doi:10.1080/14017431.2020.1846774
  • Peng J, Wang H, Zhang L, et al. Construction and efficiency analysis of prediction model for venous thromboembolism risk in the elderly after Hip fracture. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021;46(2):142–148. doi:10.11817/j.issn.1672-7347.2021.190722
  • Lopera JE, Barnes L. A single center 10-year clinical experience with superior vena cava retrievable filters. Catheter Cardiovasc Interv. 2020;95(1):1–6. doi:10.1002/ccd.28533
  • Spence LD, Gironta MG, Malde HM, et al. Acute upper extremity deep venous thrombosis: safety and effectiveness of superior vena caval filters. Radiology. 1999;210(1):53–58. doi:10.1148/radiology.210.1.r99ja1353
  • Owens CA, Bui JT, Knuttinen MG, et al. Pulmonary embolism from upper extremity deep vein thrombosis and the role of superior vena cava filters: a review of the literature. J Vasc Interv Radiol. 2010;21(6):779–787. doi:10.1016/j.jvir.2010.02.021
  • Van Ha TG, Chien AS, Funaki BS, et al. Use of retrievable compared to permanent inferior vena cava filters: a single-institution experience. Cardiovasc Intervent Radiol. 2008;31(2):308–315. doi:10.1007/s00270-007-9184-5
  • Kinney TB. Update on inferior vena cava filters. J Vasc Interv Radiol. 2003;14(4):425–440. doi:10.1097/01.RVI.0000064860.87207.77
  • Keller RE, Croswell DP, Medina GIS, et al. Paget-Schroetter syndrome in athletes: a comprehensive and systematic review. J Shoulder Elbow Surg. 2020;29(11):2417–2425. doi:10.1016/j.jse.2020.05.015
  • Bosch FTM, Nisio MD, Büller HR, et al. Diagnostic and Therapeutic Management of Upper Extremity Deep Vein Thrombosis. J Clin Med. 2020;9(7):2069. doi:10.3390/jcm9072069
  • Mustafa J, Asher I, Sthoeger Z. Upper Extremity Deep Vein Thrombosis: symptoms, Diagnosis, and Treatment. Isr Med Assoc J. 2018;20(1):53–57.
  • Cote LP, Greenberg S, Caprini JA, et al. Comparisons Between Upper and Lower Extremity Deep Vein Thrombosis: a Review of the RIETE Registry. Clin Appl Thromb Hemost. 2017;23(7):748–754. doi:10.1177/1076029616663847
  • Köse N, Yıldırım T, Akın F, et al. Prognostic role of NLR, PLR, and LMR in patients with pulmonary embolism. Bosn J Basic Med Sci. 2020;20(2):248–253. doi:10.17305/bjbms.2019.4445
  • Yao C, Zhang Z, Yao Y, et al. Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio for acute deep vein thrombosis after total joint arthroplasty: a retrospective study. J Orthop Surg Res. 2018;13(1):40. doi:10.1186/s13018-018-0745-x
  • Grilz E, Posch F, Königsbrügge O, et al. Association of Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio with the Risk of Thromboembolism and Mortality in Patients with Cancer. Thromb Haemost. 2018;118(11):1875–1884. doi:10.1055/s-0038-1673401
  • Schrottmaier WC, Mussbacher M, Salzmann M, et al. Platelet-leukocyte interplay during vascular disease. Atherosclerosis. 2020;307:109–120. doi:10.1016/j.atherosclerosis.2020.04.018
  • Koury JP, Burke CT. Endovascular management of acute upper extremity deep venous thrombosis and the use of superior vena cava filters. Semin Intervent Radiol. 2011;28(1):3–9. doi:10.1055/s-0031-1272975
  • Kearon C, Akl EA, Ornelas J, et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest. 2016;149(2):315–352. doi:10.1016/j.chest.2015.11.026